SNCA and Parkinson disease: Metformin was also found to exert neuroprotective effects on dopaminergic neurodegeneration and alpha-synuclein aggregation in Caenorhabditis elegans models of PD [51], while it alleviated motor and neuropsychiatric manifestations in the zQ175 mouse model of HD [52].